Evidence map›Paper›PMID 35431559›Full record

ArticleJournal of asthma and allergy2022

Aero-Allergen Sensitization in the General Population: Longitudinal Analyses of the LEAD (Lung Heart Social Body) Study.

Franziska Kölli, Marie-Kathrin Breyer, Sylvia Hartl, Otto Burghuber, Emiel F M Wouters, Torben Sigsgaard, Wolfgang Pohl, Gabriele Kohlböck, Robab Breyer-Kohansal

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of asthma and allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01727518 (The Austrian LEAD), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01727518 active not recruitingnot on this map

The Austrian LEAD (Lung hEart sociAl boDy) Study

TypeobservationalSponsorLudwig Boltzmann Institute for Lung HealthRan2011 to 2028Enrolled14,966ConditionsRespiration Disorders, Body Composition, Beneficial, Metabolic HealthArmsAs the LEAD study is an observational cohort study, there is no intervention to report.
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Prevalence of Central Compartment Atopic Disease (CCAD): a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Body Weight and Allergic Asthma: A Narrative Review.Journal of clinical medicine · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Franziska KölliSigmund Freud University, Faculty of Medicine, Vienna, Austria.
Marie-Kathrin BreyerLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Sylvia HartlSigmund Freud University, Faculty of Medicine, Vienna, Austria.
Otto BurghuberSigmund Freud University, Faculty of Medicine, Vienna, Austria.
Emiel F M WoutersLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Torben SigsgaardDepartment of Public Health, Section of Environment, Occupation & Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-2043-7571
Wolfgang PohlKarl Landsteiner Institute for Clinical and Experimental Pneumology, Clinic Hietzing, Vienna, Austria.
Gabriele KohlböckLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Robab Breyer-KohansalLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Ludwig Boltzmann Institute for Lung Vascular Research · ATSigmund Freud Privatuniversität Wien · ATAarhus University · DKKlinik Hietzing · ATMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Monitoring of sensitization may become a non-invasive marker of impaired epithelial barrier function related to changing environmental conditions. Objective: To longitudinally evaluate the prevalence and associated factors for positive skin prick tests (SPT) in a general population cohort. Methods: Baseline and 4-year follow-up data from the longitudinal LEAD study are used for the current analyses. Risk factors for SPT were analyzed by multivariate binary logistic regression analyses, including residence (urban/rural), sex, socioeconomic status (SES), allergic and/or respiratory diseases, lung function testing, blood eosinophils, body composition, lifestyle habits, family history, pets in household, and exposure to tobacco smoke in childhood/adolescence (6-18 years) and adulthood (≥19 years). Results: In total, 1439 children/adolescents and 9844 adults with valid SPTs were included in these analyses. The prevalence of sensitization at baseline was 37.6% and was higher in males in every age group, except 10-<15 years. Individuals with doctor´s diagnosed allergy, asthma or parental allergy were more likely to have a positive SPT; in adulthood, sensitization was more common in those with a high SES. A lower occurrence of sensitization was associated with the presence of a dog in the household in childhood/adolescence and with smoking in adulthood. The prevalence and intensity (number of positive SPT reactions) increased after a 4-year follow-up, especially in children/adolescents. Conclusion: Sensitization is common in the general Austrian population and more likely in males than females. Longitudinal monitoring of sensitization in children/adolescents may identify environmental triggers related to changes in urbanization, industrialization and domestic lifestyle. ClinicalTrials.gov NCT01727518.

Indexed as

adultsaero-allergensallergychildhood/adolescencesensitization

Identifiers

PMID35431559
PMCPMC9012316
OpenAlexW4223614719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.